Street Sweeper Paid by Hedge Fund Shorters to Write Hit Pieces
On February 10, 2011, Ms. Davis published a StreetSweeper article on vaccine developer iBio, Inc. that included the following disclosure:
Prior to the publication of this article, a third-party investor with whom TheStreetSweeper has a profit-sharing arrangement effected a “short sale” of 89,715 shares of the stock of iBio, Inc. at $5.31 a share with the intent of profiting from decreases in the price of such stock. TheStreetSweeper will share in any profits the third-party investor realizes from the short sale.
The fact that TheStreetSweeper was in cahoots with a hedge fund shorting the stock Davis attacked should speak volumes to investors about the integrity of her reporting and TheStreetSweeper.org’s real purpose. Davis is a paid hack, not an objective journalist.